Lv2
130 积分 2025-08-20 加入
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
23天前
已完结
Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity
1个月前
已完结
Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity
1个月前
已完结
Chinese SLE Treatment and Research Group (CSTAR) Registry 2009-2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
1个月前
已完结
EULAR recommendations for the treatment of systemic sclerosis: 2023 update
1个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
2个月前
已完结
Abstract 3513: CC312, a trispecific CD19-targeting co-stimulatory T cell engager, for the treatment of B cell malignancies and autoimmune diseases
9个月前
已关闭
CC312, a trispecific CD19-targeting co-stimulatory T cell engager, for the treatment of B cell malignancies and autoimmune diseases
9个月前
已关闭
a novel T-cell engager (TCE) effectively depletes B cells with reduced risk of CRS for the treatment of B cell malignancies and B cell related autoimmune diseases
9个月前
已关闭
皖公网安备34019202002308
